Form 6-K GLAXOSMITHKLINE PLC For: Oct 20
http://archive.fast-edgar.com/20141020/AB2ZN22CZ22W22Z2222G2WDZLQCJZZL2DJ62
Filed on: October 20, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves GSK's Hibsago for chronic hepatitis B treatment
- Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
- Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share